Every Form 4 that GE HealthCare Technologies Inc. (GEHC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow GEHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GEHC filings page.
GE HealthCare Technologies President and CEO Peter J. Arduini reported equity award activity involving company common stock. On February 12, 2026, he acquired 74,908 shares at $0 upon vesting of previously granted performance stock units, after performance goals were certified as met. On the same date, 33,445 shares were disposed of at $79.20 per share to satisfy tax withholding obligations related to this vesting. Following these transactions, Arduini directly beneficially owned 206,135 shares of GE HealthCare common stock.
GE HealthCare Technologies Inc. CEO, PDx Kevin Michael O'Neill reported a tax-related share withholding on common stock. On February 1, 2026, 462 shares of GE HealthCare common stock were withheld at a price of $78.97 per share to cover tax obligations associated with vesting restricted stock units.
After this transaction, O'Neill beneficially owned 22,518 shares of common stock directly. He also had an additional 59 shares reported as indirectly owned through a share incentive plan trust. The filing reflects an administrative tax withholding event rather than an open-market purchase or sale.
GE HealthCare Technologies Inc. insider filing: CEO, AVS Philip Rackliffe reported an automatic withholding of 189 shares of common stock on February 1, 2026 at $78.97 per share to cover tax obligations from vesting restricted stock units. After this tax withholding, he beneficially owns 15,393 shares of GE HealthCare common stock directly.
GE HealthCare Technologies Inc. Chief Technology Officer Taha Kass-Hout reported a routine tax-related share withholding. On February 1, 2026, 847 shares of common stock were withheld at $78.97 per share to cover tax obligations tied to vesting restricted stock units.
After this transaction, Kass-Hout beneficially owns 64,103 shares of GE HealthCare common stock in direct ownership. This filing reflects an administrative tax settlement rather than an open-market purchase or sale.
GE HealthCare Technologies Inc. Chief Accounting Officer George A. Newcomb reported a tax-related share withholding. On 02/01/2026, 108 shares of common stock at $78.97 per share were withheld to cover tax obligations tied to vesting restricted stock units.
After this transaction, Newcomb beneficially owned 7,597 shares directly and 12 shares indirectly through a family member.
GE HealthCare Technologies Inc. officer Roland Rott, CEO of Imaging, reported a routine tax-related share withholding. On February 1, 2026, 558 shares of common stock were withheld at $78.97 per share to cover tax obligations from vesting restricted stock units. After this transaction, Rott directly owned 28,564 shares of GE HealthCare common stock.
GE HealthCare Technologies Inc. GC & Corporate Secretary Frank R. Jimenez reported an automatic share withholding related to equity compensation. On February 1, 2026, 947 shares of common stock were withheld at $78.97 per share to cover tax obligations on vested restricted stock units. After this transaction, he directly beneficially owned 67,546 shares of GE HealthCare common stock.
GE HealthCare Technologies Inc.’s Chief Financial Officer, James Saccaro, reported a routine tax‑related share withholding. On February 1, 2026, 948 shares of common stock were withheld at $78.97 per share to cover tax obligations from vesting restricted stock units. After this transaction, Saccaro beneficially owned 57,646 shares of GE HealthCare Technologies common stock, held directly.
GE HealthCare Technologies Inc. President and CEO Peter J. Arduini had 3,210 shares of common stock withheld on February 1, 2026 to cover taxes on vesting restricted stock units. The shares were valued at $78.97 each for this tax withholding event.
After this transaction, Arduini directly beneficially owned 164,672 shares of GE HealthCare Technologies Inc. common stock. This was a tax-related share withholding by the company rather than an open-market sale.